Report overview
The deproteinized calf blood extract is a sterile solution containing inorganic substance and small molecule organic substance made from fresh calf blood or serum by deproteinization, concentration, ultrafiltration or dialysis.
This report aims to provide a comprehensive presentation of the global market for Actovegin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Actovegin. This report contains market size and forecasts of Actovegin in global, including the following market information:
Global Actovegin Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Actovegin market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Intravenous Drip Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Actovegin include Nycomed (Takeda Pharmaceutical), Heilongjiang Jiangshi Pharmaceutical, Jilin Connell Pharmaceutical, Harbin Shengtai Biopharmaceutical, Wuhan Renfu Pharmaceutical, Hunan Wuzhoutong Pharmaceutical, Heilongjiang Zhenbao Island Pharmaceutical, Jinzhou Aohong Pharmaceutical Co. LTD and Wuhan Hualong Biopharmaceutical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Actovegin companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Actovegin Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Actovegin Market Segment Percentages, by Type, 2022 (%)
Intravenous Drip
Arterial Injection
Intramuscular Injection
Bladder Perfusion
Oral Medicine
Local Drug Delivery
Global Actovegin Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Actovegin Market Segment Percentages, by Application, 2022 (%)
Adult
Teenagers
Infants and Young Children
Other
Global Actovegin Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Actovegin Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Actovegin revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Actovegin revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Nycomed (Takeda Pharmaceutical)
Heilongjiang Jiangshi Pharmaceutical
Jilin Connell Pharmaceutical
Harbin Shengtai Biopharmaceutical
Wuhan Renfu Pharmaceutical
Hunan Wuzhoutong Pharmaceutical
Heilongjiang Zhenbao Island Pharmaceutical
Jinzhou Aohong Pharmaceutical Co. LTD
Wuhan Hualong Biopharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Actovegin, market overview.
Chapter 2: Global Actovegin market size in revenue.
Chapter 3: Detailed analysis of Actovegin company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Actovegin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
